Abstract
Orthoclone OKT3 has been used in the prophylaxis or treatment of acute graft-versus-host disease (GVHD). No previous report of Orthoclone OKT3 in the treatment of marrow allograft failure has been found. Here a case of chronic myelocytic leukemia is presented where the patient received unrelated bone marrow transplantation and developed late graft failure. After failing all other immunosuppressive agents, marrow allograft was successfully rescued by the use of Orthoclone OKT3.
Original language | English |
---|---|
Pages (from-to) | 126-131 |
Number of pages | 6 |
Journal | Chinese Medical Journal (Taipei) |
Volume | 59 |
Issue number | 2 |
Publication status | Published - 1997 |
Externally published | Yes |
Keywords
- bone marrow transplantation
- graft failure
- OKT3
ASJC Scopus subject areas
- General Medicine